Dr. Marty Makary is out as FDA commissioner
NBC News • • general
Key Points:
- Dr. Marty Makary has departed as commissioner of the Food and Drug Administration, marking the fourth high-profile exit from the Trump administration this year, though it remains unclear if he was fired or asked to resign.
- President Trump recently authorized fruit-flavored vapes for adults, fulfilling a key 2024 campaign promise, amid industry pressure and FDA decisions during Makary’s tenure.
- Makary faced criticism from Republican lawmakers over his handling of the FDA review of the abortion medication mifepristone, which remains unreleased and was reportedly delayed until after the midterm elections.
- The Supreme Court recently allowed continued nationwide access to mifepristone despite lower court restrictions, intensifying scrutiny on the FDA's role and Makary’s management.
- Experts emphasize the need for Makary’s successor to address significant public health challenges, including emerging threats like hantavirus, highlighting global interconnectedness in health issues.